The ESGCT 33rd Annual Congress will be held October 27-30, 2026, in Hamburg, Germany.

Cellectis will present two posters:

P0208: In vivo editing of human apoc3 by tale base editor normalizes triglyceride levels in animal models

Presenter: Julien Valton, Ph.D., Vice President Gene Therapy

Presentation date/time: Thursday, October 29, 2026 from 2 to 4 p.m. CET.   

*******************

P0956: TALE: developing a global framework for genome engineering 

Presenter: Alexandre Juillerat, Vice President Gene Editing

Presentation date/time:  Thursday, October 29, 2026 from 2 to 4 p.m. CET.

Link to register for the conference: https://www.esgctcongress.com/